EUVIMEDOpdag EUVIMED
Crossref

Ribonucleoprotein Transfection for CRISPR/Cas9‐Mediated Gene Knockout in Primary T Cells

Soyoung A Oh, Akiko Seki, Sascha Rutz

Current Protocols in Immunology · 2019-02 · 124 (1)

DOI: 10.1002/cpim.69 ↗

At a glance

Journal article in Current Protocols in Immunology, published online on 2018-10-18. Written by Soyoung A Oh and 2 co-authors. Institution: Department of Cancer Immunology, Genentech, South San Francisco, California. Cited 55 times so far (Crossref); 20 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

CRISPR/Cas9 has enabled the rapid and efficient generation of gene knockouts across various cell types of several species. T cells are central players in adaptive immune responses. Gene editing in primary T cells not only represents a valuable research tool, but is also critical for next generation immunotherapies, such as CAR T cells. Broad application of CRIPSR/Cas9 for gene editing in primary T cells has been hampered by limitations in transfection efficiency and the requirement for TCR stimulation. In this article, we provide a detailed protocol for Cas9/gRNA ribonucleoprotein (RNP) transfection of primary mouse and human T cells without the need for TCR stimulation that achieves near complete loss of target gene expression at the population level. This approach enables rapid target discovery and validation in both mouse and human primary T cells. © 2018 by John Wiley & Sons, Inc.

Subjects

MeSH terms (MEDLINE)

AnimalsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCRISPR-Cas SystemsGene EditingHumansMiceMice, KnockoutRibonucleoproteinsTransfection

Author keywords

CRISPRCas9RNPgRNAgene knockoutnucleofectionprimary human T cellsprimary mouse T cells

Substances

Ribonucleoproteins

Authors and institutions

  • Department of Cancer Immunology, Genentech, South San Francisco, California.

Cite

APA

Oh, S. A., Seki, A., & Rutz, S. (2019). Ribonucleoprotein Transfection for CRISPR/Cas9‐Mediated Gene Knockout in Primary T Cells. Current Protocols in Immunology, 124(1). https://doi.org/10.1002/cpim.69

Vancouver

Oh SA, Seki A, Rutz S. Ribonucleoprotein Transfection for CRISPR/Cas9‐Mediated Gene Knockout in Primary T Cells. Current Protocols in Immunology. 2019;124(1). doi:10.1002/cpim.69

BibTeX
@article{Oh2019,
  author = {Oh, Soyoung A and Seki, Akiko and Rutz, Sascha},
  title = {Ribonucleoprotein Transfection for CRISPR/Cas9‐Mediated Gene Knockout in Primary T Cells},
  journal = {Current Protocols in Immunology},
  year = {2019},
  volume = {124},
  number = {1},
  doi = {10.1002/cpim.69}
}
Start for free →